Table of Content

Open Access

REVIEW

Surveillance for liver complications after the Fontan procedure

Moira B. Hilscher1, Jonathan N. Johnson2,3, Frank Cetta2,3, David J. Driscoll2,3, John J. Poterucha1, William Sanchez1, Heidi M. Connolly3, Patrick S. Kamath1
1 Department of Medicine/Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
2 Department of Pediatrics and Adolescent Medicine/Division of Pediatric Cardiology, Mayo Clinic, Rochester, Minnesota, USA
3 Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA
* Corresponding Author: Jonathan N. Johnson, Mayo Clinic, Gonda 6-138, 200 First Street SW, Rochester, MN 55905, USA. Email:

Congenital Heart Disease 2017, 12(2), 124-132. https://doi.org/10.1111/chd.12446

Abstract

The physiological consequences of the Fontan circulation impose risk for hepatic dysfunction and may culminate in hepatic fibrosis, cirrhosis, and hepatocellular carcinoma. Consensus regarding appropriate surveillance modalities to diagnose liver disease in Fontan patients is lacking, in part due to the relative lack of strong evidence and prospective studies in this patient population. The goal of this paper is to critically review the current evidence and provide recommendations for the surveillance of hepatic complications in the post-Fontan patient population.

Keywords

cirrhosis, Fontan

Cite This Article

Hilscher, M. B., Johnson, J. N., Cetta, F., Driscoll, D. J., Poterucha, J. J. et al. (2017). Surveillance for liver complications after the Fontan procedure. Congenital Heart Disease, 12(2), 124–132.



This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 855

    View

  • 889

    Download

  • 0

    Like

Related articles

Share Link

WeChat scan